Could a simple supplement tame diabetes and heart risk?
NCT ID NCT07503548
First seen Apr 26, 2026 · Last updated Jun 23, 2026 · Updated 8 times
Summary
This study tests whether tributyrin, a dietary supplement that turns into butyrate in the body, can improve blood sugar control, reduce inflammation, and lower heart disease risk in people with type 2 diabetes. Sixty participants at high risk for heart problems will receive either tributyrin or a placebo alongside their usual diabetes treatment for 12 weeks. The goal is to see if this safe, natural compound can offer extra benefits beyond standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Matareya Teaching Hospital
Cairo, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tributyrin (a dietary supplement that turns into butyrate in the body)
What this could lead to
If it works, this could point toward a simple, safe supplement to help manage blood sugar and reduce heart disease risk in people with type 2 diabetes.
What could go wrong
This is a small, early-phase trial with only 60 participants, so results may not apply to everyone. The supplement may not show significant benefits over standard care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.